ASHLIE COLLINS: Open Payments
NPI 1780275255 · MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,523 in 110 payments from 14 companies in 2025. Trend: 2023 $661 · 2024 $984 · 2025 $2,523
Food & beverage: $2,515Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $522 |
| Supernus Pharmaceuticals, Inc. | 15 | $384 |
| Axsome Therapeutics, Inc. | 17 | $323 |
| Vanda Pharmaceuticals Inc. | 12 | $263 |
| Alkermes, Inc. | 9 | $257 |
| Otsuka America Pharmaceutical, Inc. | 11 | $184 |
| Neurocrine BioSciences, Inc. | 1 | $121 |
| Lundbeck LLC | 5 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $99 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $80 |
Products named: VRAYLAR, Qelbree, Auvelity, REXULTI, FANAPT, ARISTADA, LYBALVI, INGREZZA.
Industry payments across OH — which companies pay providers there.
